Related Experiment Video
Updated: Jun 25, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Aggressive Anticoagulation after TJA: an evaluation of the ACCP guidelines for Thromboprophylaxis
Javad Parvizi1, Lauren K Kahl, Chelsea Dalsey
1Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. parvj@aol.com
Insights
Orthopaedic surgery patients face high risks of thromboembolic disease. The American Association of Orthopaedic Surgeons (AAOS) guidelines offer a safer thromboprophylaxis approach by considering anticoagulation risks, unlike the American College of Chest Physicians (ACCP) guidelines.
Area of Science:
- Orthopaedic Surgery
- Thromboprophylaxis
- Anticoagulation Therapy
Background:
- Thromboembolic disease, including pulmonary embolism and deep vein thrombosis (DVT), is a significant concern following orthopaedic surgery.
- Anticoagulant administration is a common strategy to mitigate these risks, with established guidelines from professional organizations.
- Current guidelines from the American College of Chest Physicians (ACCP) and the American Association of Orthopaedic Surgeons (AAOS) offer differing recommendations for antithrombotic protocols.
Purpose of the Study:
- To compare the American College of Chest Physicians (ACCP) and American Association of Orthopaedic Surgeons (AAOS) guidelines for thromboprophylaxis after orthopaedic surgery.
- To evaluate the potential complications associated with aggressive anticoagulation regimens recommended by the ACCP.
- To advocate for the AAOS guidelines as a potentially safer alternative for patients undergoing orthopaedic procedures.
Main Methods:
- Review and comparison of existing ACCP and AAOS guidelines on antithrombotic therapy post-orthopaedic surgery.
- Analysis of potential complications associated with ACCP-recommended anticoagulation, such as bleeding events, thrombocytopenia, and infection.
- Evaluation of the AAOS guideline's approach, including the use of aspirin, mechanical compression, and low-dose warfarin.
Main Results:
- The ACCP guidelines are considered potentially excessive and may not fully account for anticoagulation-related complications.
- The AAOS guidelines focus on preventing pulmonary embolism and consider a broader range of risks, including bleeding and infection.
- The AAOS guidelines permit the use of aspirin with mechanical compression devices and low-dose warfarin, offering alternative thromboprophylaxis strategies.
Conclusions:
- The ACCP guidelines may lead to significant complications due to aggressive anticoagulation.
- The AAOS guidelines provide a more balanced approach to thromboprophylaxis, considering patient safety and potential adverse events.
- The AAOS guidelines represent a potentially safer option for managing thromboembolic risk in orthopaedic surgery patients.
Abstract:
Thromboembolic disease is common after orthopaedic surgery. In an effort to minimize the risk of pulmonary embolism and deep vein thrombosis (DVT), anticoagulation administration has become a common practice. Both the American College of Chest Physicians (ACCP) and the American Association of Orthopaedic Surgeons (AAOS) have published guidelines recommending antithrombotic protocols. The ACCP guidelines are excessive and do not adequately evaluate the complications resulting from aggressive anticoagulation. These complications include, but are not limited to, major and minor bleeding events, thrombocytopenia, subsequent periprosthetic infection, and complications with spinal or epidural anesthesia. The AAOS guidelines generated by a group of orthopedic surgeons evaluate the efficacy of various agents in preventing pulmonary embolus and not distal DVT. They differ from the AACP guidelines in some aspects. The AAOS guidelines accept the use of aspirin combined with mechanical compression devices, and low-dose warfarin therapy. We believe that the AAOS guidelines for thromboprophylaxis take into account all risks associated with anticoagulation therapy and may prove to be a safer option for our patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care